UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | C000000450 |
|---|---|
| Receipt number | R000000546 |
| Scientific Title | Phase I/II study on combination therapy consisting of a fixed dose-rate infusion of gemcitabine with oral fluorinated pyrimidine compound S-1 (FGS) in patients with gemcitabine-refractory advanced pancreatic cancer |
| Date of disclosure of the study information | 2006/07/20 |
| Last modified on | 2011/07/18 21:58:39 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2006/07/18 19:48:17 | ||
| 2 | Update | 2009/01/19 18:36:32 | Key inclusion criteria Key inclusion criteria |
|
| 3 | Update | 2009/05/26 20:17:22 | Recruitment status |
|
| 4 | Update | 2010/01/18 20:59:41 | Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 5 | Update | 2010/01/18 21:01:13 | Publication of results |
|
| 6 | Update | 2011/07/18 21:58:39 | Recruitment status |
